Katrina Helen Tayton-Martin

Affiliations

  • Chief Business & Strgy Officer at Adaptimmune Therapeutics Plc (ADAP), 2024-01-17
  • Director at Trillium Therapeutics Inc. (TRIL), 2021-11-19
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ADAP $8.74 200,000 $1,748,180.00 0 2020-08-03 Filing
ADAP $5.00 50,000 $250,000.00 0 2020-01-13 Filing
ADAP $4.00 50,000 $200,000.00 0 2020-01-13 Filing